Navigation Links
Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement
Date:6/2/2008

Regulatory Hurdle Clears Way for Approval of Merger

CHICAGO, June 2 /PRNewswire-FirstCall/ -- Allscripts, the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced today that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, with respect to the merger agreement announced on March 18, 2008 between Allscripts and Misys Healthcare to form Allscripts-Misys Healthcare Solutions, Inc., has expired.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

The expiration of the Hart-Scott-Rodino waiting period satisfies one of the closing conditions. The transaction remains subject to other customary closing conditions.

Misys Healthcare is a division of Misys plc (FTSE: MSY.L), the global applications software and services company.

About Allscripts

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The company's unique solutions inform, connect and transform healthcare, delivering improved care at lower cost. More than 40,000 physicians and thousands of other healthcare professionals in clinics, hospitals and extended care facilities nationwide utilize Allscripts to automate everyday tasks such as writing prescriptions, documenting patient care, managing billing and scheduling, and safely discharging patients, as well as to connect with key information and stakeholders in the healthcare system. To learn more, visit Allscripts at http://www.allscripts.com.

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts' actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company's 2007 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at http://www.sec.gov.


'/>"/>
SOURCE Allscripts
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
2. PCMA Statement on Independent Pharmacy Antitrust Legislation
3. Former FTC Attorney Christine White Joins Crowell & Morings Health Care and Antitrust Groups
4. Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
5. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
6. Radiation seed implant decreases risk of death over watchful waiting
7. New Heart Pump Helps Women Awaiting Transplants
8. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
9. Blacks awaiting lung transplants more likely to die or be denied than whites
10. Blacks Awaiting Lung Transplants Face Poorer Outcomes
11. Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... At Creekwood Dental Arts, Drs. Donna G. Miller and Michelle Hinds are ... in Waco, TX, using the latest dental technology for digital imagery and bite ... details in the oral cavity for accurate diagnoses and customized care plans. These tools ...
(Date:7/20/2017)... ... July 19, 2017 , ... A July 7th ... to, or worsen, varicose veins in some patients, according to medical experts. Washington ... not-so-good practices, like excessive sitting or standing, or regularly nicking yourself while shaving ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... , What Strategic Decisions Do You Need to Consider?, **An FDAnews Webinar**, Aug. ... , 42 CFR Part 11, “Final Rule for Clinical Trials Registration and Results ...
(Date:7/18/2017)... ... July 18, 2017 , ... Heritage Woods of Benton, a Gardant ... 12:30 p.m. on Aug. 15. , The community, which is located at 1305 Bailey ... who need some help to maintain their independence. , The lunch menu will include ...
(Date:7/17/2017)... ... July 17, 2017 , ... McGraw Family Pledges $3 Million for New Learning ... of Healthcare Clinicians , NORWALK, Connecticut – July 17, 2017 – The McGraw ... in community health by pledging up to $3 million in a challenge gift to ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017 In vitro diagnostics ... start of May, at least ten diagnostic companies have ... investments, public offerings and a loan facility.  The size ... almost $80 million.  Kalorama Information provides a monthly ... Diagnostics Knowledge Center. ...
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
(Date:6/27/2017)... 2017   NuEyes (NuEyes Technologies Inc.) today announced ... its growth in helping the legally blind live more independent ... the leading developer of augmented, virtual and mixed reality smartglasses ... The undisclosed funding amount was provided by strategic partners as ... offices in Abu Dhabi , ...
Breaking Medicine Technology: